Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Eur J Biochem ; 132(3): 531-6, 1983 May 16.
Artigo em Inglês | MEDLINE | ID: mdl-6852012

RESUMO

Phosphoenolpyruvate was found to be transported across the erythrocyte membrane by a carrier-mediated transport system. The transport of phosphoenolpyruvate was competitively inhibited by inorganic phosphate (Ki = 24 mM) and pyridoxal 5-phosphate (Ki = 0.2 mM), whereas the transport was noncompetitively inhibited by L(+)-lactate (Ki = 37 mM). Specific inhibitors for the inorganic anion transport system such as 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid and 4,4'-dinitrostilbene-2,2'-disulfonic acid strongly inhibited the phosphoenolpyruvate transport. The transport was irreversibly inhibited by treating erythrocytes with pyridoxal 5-phosphate and NaBH4. Transport activities of phosphoenolpyruvate and inorganic phosphate in the treated cells were similarly inhibited by pyridoxal 5-phosphate depending on its concentrations. 4,4'-Dinitrostilbene-2,2'-disulfonic acid protected both transport activities against the pyridoxal 5-phosphate/NaBH4 treatment. The major integral membrane protein, band 3, was preferentially labelled by treating erythrocytes with pyridoxal 5-phosphate and NaB[3H]H4. The radioactive incorporation into band 3 was confirmed by two-dimensional gel electrophoresis combining isoelectric focusing in the first dimension and sodium dodecyl sulfate/polyacrylamide gel electrophoresis in the second dimension. Taken together, these results suggest that band 3 mediates the transport of phosphoenolpyruvate as well as inorganic phosphate.


Assuntos
Proteínas Sanguíneas/metabolismo , Membrana Eritrocítica/metabolismo , Eritrócitos/metabolismo , Proteínas de Membrana/sangue , Fosfoenolpiruvato/sangue , Proteína 1 de Troca de Ânion do Eritrócito , Transporte Biológico/efeitos dos fármacos , Humanos , Técnicas In Vitro , Fosfatos/sangue , Fosfatos/farmacologia , Fosfato de Piridoxal/farmacologia
2.
Transfusion ; 23(1): 1-7, 1983.
Artigo em Inglês | MEDLINE | ID: mdl-6829052

RESUMO

Stored, depleted RBC were rejuvenated with respect to their levels of adenosine triphosphate (ATP), 2,3-diphosphoglycerate (2,3-DPG), and P50 by acid-citrate-dextrose perservatives containing phosphoenolpyruvate (PEP) without sucrose. The restorations of P50 and 2,3-DPG were dependent on the phosphoenolpyruvate concentration. Erythrocyte P50 and 2,3-DPG, even after treatment with these preservatives, decreased with increasing storage period, but the P50 and 2,3-DPG of five-week-old blood were still higher than the corresponding values of fresh blood. ATP concentration was also increased by treating stored blood with preservatives containing phosphoenolpyruvate, but the elevated ATP of five-week-old blood was only about 50 percent of fresh blood. The ATP level could not be raised further by increasing phosphoenolpyruvate concentration but was improved by supplementation with adenine and nucleosides. Incubation of stored blood with 15 mM phosphoenolpyruvate was sufficient to restore ATP, 2,3-DPG and P50 of three-week-old blood to nearly normal. The results of these studies indicate that sucrose is not necessary for PEP to be effective as a preservative additive.


Assuntos
Anticoagulantes/farmacologia , Preservação de Sangue/métodos , Ácido Cítrico , Glucose/análogos & derivados , Fosfoenolpiruvato/farmacologia , 2,3-Difosfoglicerato , Trifosfato de Adenosina/sangue , Ácidos Difosfoglicéricos/sangue , Envelhecimento Eritrocítico/efeitos dos fármacos , Glucose/farmacologia , Humanos , Concentração de Íons de Hidrogênio , Fatores de Tempo
3.
Tokai J Exp Clin Med ; 7 Suppl: 113-9, 1982.
Artigo em Inglês | MEDLINE | ID: mdl-7186217

RESUMO

Phosphoenolpyruvate is transported across the erythrocyte membrane by a carrier-mediated transport system. The transport of phosphoenolpyruvate was competitively inhibited by inorganic phosphate (Ki = 24 mM) and pyridoxal 5-P (Ki = 0.2 mM), whereas the transport was non-competitively inhibited by L-(+)-lactate (Ki = 37 mM). Specific inhibitors for the inorganic anion transport system such as 4,4'-diisothiocyanostilbene-2,2'-disulfonic acid strongly inhibited the phosphoenolpyruvate transport. Inhibitors for the monocarboxylate transport system, including p-chlormercuribenzoic acid and alpha-cyano-4-hydroxycinnamate, had less inhibitory effects on the phosphoenolpyruvate transport as high as 100 microM. The transport was inhibited irreversibly by treating erythrocytes with pryridoxal 5-P/NaBH4. Transport activities of phosphoenolopyruvate and inorganic phosphate in the treated cells were similarly inhibited depending on the pyridoxal 5-P concentration. The major integral membrane protein, Band 3, was preferentially labelled by treating erythrocytes with pyridoxal 5-P/[3H]-NaBH4. These results suggest that Band 3 mediates the transport of phosphenolopyrvate as well as inorganic phosphate.


Assuntos
Membrana Eritrocítica/metabolismo , Eritrócitos/metabolismo , Fosfoenolpiruvato/sangue , Marcadores de Afinidade/farmacologia , Proteína 1 de Troca de Ânion do Eritrócito , Ânions , Transporte Biológico/efeitos dos fármacos , Proteínas Sanguíneas/metabolismo , Boroidretos/farmacologia , Membrana Eritrocítica/efeitos dos fármacos , Humanos , Cinética , Lactatos/farmacologia , Ácido Láctico , Proteínas de Membrana/sangue , Proteínas de Membrana/isolamento & purificação , Fosfato de Piridoxal/farmacologia , Fluoreto de Sódio/farmacologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA